No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

GALEN regimen, Phase 2 trial

byKathleen Lau

December 31, 2021

in StudyGraphics

Reading Time: 1 min read

RELATED REPORTS

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

Spinal instability may be the primary cause of pain in sacral metastases as opposed to neurologic compromise

Enfortumab vedotin plus pembrolizumab is more effective than platinum-based chemotherapy in metastatic urothelial carcinoma

Tags: #cancer advanced follicular lymphoma advanced lymphoma blood blood cancer cancer chemo-free chemotherapy complete response rate CRR efficacy outcomes febrile neutropenia FL follicular lymphoma GALEN hematology high tumor burden high tumour burden induction infection infusion-related reaction IWG 1999 Criteria lenalidomide maintenance neutropenia Obinutuzumab oncology os overall survival pfs previously untreated lymphoma progression-free survival skin reaction survival outcomes untreated lymphoma

Moderate caffeine intake may not be associated with cardiometabolic pregnancy complications

RelatedReports

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Chronic Disease

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

July 15, 2026

Epidural corticosteroid injections provide only short-term radiculopathy pain relief

Chronic Disease

Spinal instability may be the primary cause of pain in sacral metastases as opposed to neurologic compromise

July 14, 2026

Chronic Disease

Enfortumab vedotin plus pembrolizumab is more effective than platinum-based chemotherapy in metastatic urothelial carcinoma

July 9, 2026

Obstetric scoring systems overestimate cases of severe sepsis

All Specialties

2 Minute Medicine Rewind July 6, 2026

July 7, 2026

Influenza vaccine not associated with increased risk of epilepsy in children

Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

2 Minute Medicine Rewind January 3, 2022

Kangaroo mother care linked to better neonatal outcomes

Mediterranean diet and mindfulness-strategies reduced risk of low-birth-weight newborns

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result